The MMRF CureCloud Research Initiative, a novel direct-to-patient observational study developed by the Multiple Myeloma Research Foundation (MMRF), collects and aggregates de-identified genomic and ...
Perhaps it makes sense that the best formula for fighting cancer came not from scientists, or industry, or government, but from twin sisters. Kathy Giusti and Karen Anderson share the same genome.
NORWALK, Conn.--(BUSINESS WIRE)--The Multiple Myeloma Research Foundation (MMRF) today announced that findings from three studies based on analyses of its CoMMpass℠ and CureCloud℠ datasets will be ...
Kristie L. Kahl: What is the rate of myeloma diagnoses in the US each year? Mary Derome: Myeloma is the second most common blood cancer behind non-Hodgkin lymphoma in the US, but with that said, it ...
Findings reinforce the value of the MMRF’s integrated clinical and translational research expertise to provide a deeper understanding of multiple myeloma and improve how the disease is treated The ...
NORWALK, Conn.--(BUSINESS WIRE)--The Multiple Myeloma Research Foundation (MMRF) announced today that Hearn Jay Cho, MD, PhD, will serve as the organization’s Chief Medical Officer (CMO). As CMO, Dr.
NORWALK, Conn., Sept. 20, 2025 (GLOBE NEWSWIRE) -- Today, the Multiple Myeloma Research Foundation® (MMRF) announced that data generated from several MMRF initiatives were presented at the prestigious ...
In 1996, Kathy Giusti was a 37-year-old rising star in the pharmaceutical industry, with a young child. When she learned she had multiple myeloma, the news floored her. Not only did she not resemble ...
Norwalk, Conn., March 30, 2022 — The Multiple Myeloma Research Foundation (MMRF) has appointed George Mulligan, Ph.D., as its new Chief Scientific Officer effective immediately. In this role, Dr.
The Multiple Myeloma Research Foundation (MMRF) has appointed William K. Bowes, Jr., Marie Pinizzotto, and Pat Williams to the foundation’s board of directors. The appointments bring experiences in ...
At 37 years old, Kathy Giusti was handed what amounted to a death sentence when she was diagnosed with multiple myeloma: A rare, fatal blood cancer. Her doctors told her she had only three years to ...
Today, the Multiple Myeloma Research Foundation (MMRF) announced that advances resulting from its investments in immunotherapy, clinical trials, and in prevention will be presented at the 62 nd ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results